KIMS Share Price Target 2024 2025 2030 2040 2050 – The Krishna Institute of Medical Sciences (KIMS) is a renowned hospital chain established by Dr. Bhaskar Rao Bollineni in 2000 in Nellore, India. It operates 12 hospitals across Andhra Pradesh, Telangana, and Maharashtra, providing a wide range of medical services including critical care, endoscopic surgeries, cardiology, oncology, urology, neurosurgery, plastic surgery, and renal transplant services.
If you are an expert looking to invest in KIMS shares for the long term, it is crucial to analyze the potential opportunities and obstacles that may impact the company’s stock performance in the years ahead. Our KIMS Share Price target is based on a deep technical analysis and past performance of the company to help you make an informed decision.
Before investing in KIMS stock, it is essential to understand the company’s business model and financial data thoroughly. Once you have a clear understanding of KIMS’s operations and financial strength, you can determine whether the stock is a good buy or not.
Our KIMS Share Price Target provides a detailed analysis of the stock’s potential growth and performance for the years 2024, 2025, 2030, and 2040. This analysis can help you make an informed investment decision.
Contents
- 1 About Krishna Institute of Medical Sciences (KIMS)
- 2 Financial Overview of Krishna Institute of Medical Sciences (KIMS)
- 3 KIMS Share Price Chart
- 4 Advantages and Disadvantages of investing in KIMS
- 5 KIMS Share Price Target 2024 to 2050
- 5.1 KIMS Share Price Target 2024
- 5.2 KIMS Share Price Target 2025
- 5.3 KIMS Share Price Target 2026
- 5.4 KIMS Share Price Target 2027
- 5.5 KIMS Share Price Target 2028
- 5.6 KIMS Share Price Target 2029
- 5.7 KIMS Share Price Target 2030
- 5.8 KIMS Share Price Target 2040
- 5.9 KIMS Share Price Target 2050
- 5.10 KIMS Share Price Target 2060
- 6 Video Related to KIMS Share Price Target
- 7 KIMS Share Price Target Conclusion
- 8 KIMS Share Price Target FAQs
- 9 Disclaimer
About Krishna Institute of Medical Sciences (KIMS)
The Krishna Institute of Medical Sciences (KIMS) is an esteemed hospital chain situated in Telangana, India. Founded by Dr. Bhaskar Rao Bollineni in 2000 in Nellore, the KIMS Group currently oversees 12 hospitals spanning Andhra Pradesh, Telangana, and Maharashtra.
These facilities offer comprehensive medical services, encompassing critical care, endoscopic surgeries, dialysis, cardiology, oncology, urology, neurosurgery, plastic surgery, oral and maxillofacial surgery, and a distinguished renal transplant unit.
Notably, the KIMS Hospital Group holds certifications from NABH (National Accreditation Board for Hospitals & Healthcare Providers) and NABL (National Accreditation Board for Testing and Calibration Laboratories).
Furthermore, it is publicly listed on both the BSE (Bombay Stock Exchange) and the NSE (National Stock Exchange). Noteworthy branches within the KIMS Group include:
- Stock Symbol: KIMS
- Current Stock Price: ₹2007.35
- Market Cap: ₹149,031.8 crore
- 52-Week High: ₹2356.4
- 52-Week Low: ₹1581.05
- PE Ratio: 51.34 (High PE)
- Dividend Yield: 0.00%
- Face Value: ₹10.00
- EPS (Trailing Twelve Months): ₹38.76 (-6.78% YoY)
- Book Value Per Share: ₹176.27
Also Read – When will Raymond reach to Rs.5000? Raymond Share Price Target 2024 2025 2030 2040 2050
Financial Overview of Krishna Institute of Medical Sciences (KIMS)
| Stock Name | Krishna Institute of Medical Sciences (KIMS) |
| Sector | Hospital & Healthcare Services |
| Industry | Hospital |
| Open | 1,978.30 |
| Previous Close | 1,965.35 |
| Volume | 59,968 |
| Value (Lacs) | 1,202.45 |
| i VWAP | 2,004.38 |
| Beta | 0.33 |
| Mkt Cap (Rs. Cr.) | 16,046 |
| High | 2,019.45 |
| Low | 1,970.45 |
| UC Limit | 2,358.40 |
| LC Limit | 1,572.30 |
| 52 Week High | 2,356.40 |
| 52 Week Low | 1,581.05 |
| Face Value | 10 |
| All Time High | 2,356.40 |
| All Time Low | 937.55 |
| 20D Avg Volume | 87,254 |
| 20D Avg Delivery(%) | — |
| Book Value Per Share | 233.23 |
| Dividend Yield | — |
| TTM EPS | 29.41(-6.78% YoY) |
| TTM PE | 68.18(High PE) |
| P/B | 8.60(Average P/B) |
| Sector PE | 79.57 |
Advantages and Disadvantages of investing in KIMS
Advantages of investing in KIMS | Disadvantages of investing in KIMS |
| Strong Regional Presence – KIMS has a significant presence in Tier I and Tier II/III cities in Andhra Pradesh and Telangana, showing strong regional focus and potential for stability and growth. | Lower Realizations – KIMS provides services at prices 20-30% lower than its competitors, which affects the average revenue per bed. |
| Operational Efficiency – Despite lower average revenue per operating bed (ARPOB), KIMS has improved its adjusted EBITDA margins by leveraging operations and controlling costs. | Limited Geographical Diversification – KIMS is primarily concentrated in two states, which could expose the company to regional risks. |
| Industry-Leading Margins – KIMS has impressive operating margins, which may appeal to investors. | Healthcare Sector Volatility – The volatility of the healthcare sector is influenced by regulatory changes, medical advancements, and economic cycles. |
| Net Cash Positive – The company has a strong balance sheet with net cash, reducing financial risk. | Competition – Rival hospital chains and new market entrants present competitive challenges for KIMS. |
| Revenue and Earnings Growth – KIMS achieved a robust revenue CAGR of 24% and adjusted earnings CAGR of 40% between FY18 and FY211. | Dependence on Doctors – KIMS’s business growth relies heavily on retaining its doctors. |
| Long-Term Healthcare Demand – The post-pandemic world emphasizes healthcare services, providing growth potential for KIMS. | IPO Lock-In Period – Following the IPO, certain shareholders may face restrictions on selling their shares for a specific period. |
| PE Ratio and Valuation – The IPO valuation (PE of 31x FY21 earnings) is reasonable compared to peers. | Market Sentiment – Stock performance may be influenced by investor sentiment and market conditions. |
| Potential Listing Gains – Short-term investors may benefit from listing gains after the IPO. | Potential Regulatory Risks – KIMS’s operations can be significantly impacted by healthcare regulations and policies. |
| Year | Min Target Price | Max Target Price |
|---|---|---|
| 2024 | ₹1874.2 | ₹2368.1 |
| 2025 | ₹2108.25 | ₹2612.8 |
| 2026 | ₹2395.56 | ₹2729.4 |
| 2027 | ₹2627.80 | ₹2943.2 |
| 2028 | ₹2698.30 | ₹3115.42 |
| 2029 | ₹3098.49 | ₹3448.90 |
| 2030 | ₹3112.40 | ₹3999.40 |
| 2040 | ₹4298.58 | ₹5478.81 |
| 2050 | ₹7,491.28 | ₹9,582.30 |
| 2060 | ₹9,217.60 | ₹10,939.26 |
Also Read – Titan Share Price Target 2024 2025 2030 2040 2050
– Minimum Target Price – ₹1874.20
– Maximum Target Price – ₹2368.1
– Minimum Target Price – ₹2108.25
– Maximum Target Price – ₹2612.8
– Minimum Target Price – ₹2395.56
– Maximum Target Price – ₹2729.4
– Minimum Target Price – ₹2627.80
– Maximum Target Price – ₹2943.2
– Minimum Target Price – ₹2698.30
– Maximum Target Price – ₹3115.42
– Minimum Target Price – ₹3098.49
– Maximum Target Price – ₹3448.90
– Minimum Target Price – ₹3112.40
– Maximum Target Price – ₹3999.40
– Minimum Target Price – ₹4298.58
– Maximum Target Price – ₹5478.81
– Minimum Target Price – ₹7491.28
– Maximum Target Price – ₹9582.30
– Minimum Target Price – ₹9217.60
– Maximum Target Price – ₹10939.26
We, at priceforecaster, provide fundamental and technical analysis of companies like KIMS. Our team of experts conducts thorough research and analysis to provide you with accurate and reliable information, based on recent trading data and algorithms that can aid in making informed investment decisions. These predictions can serve as potential support and resistance levels for the stock in the coming years. [KIMS Share Price Target 2024]
The Krishna Institute of Medical Sciences (KIMS) is a prestigious hospital chain renowned for providing a wide range of comprehensive medical services. These services include critical care, endoscopic surgeries, dialysis, cardiology, oncology, urology, neurosurgery, plastic surgery, oral and maxillofacial surgery, as well as a distinguished renal transplant unit.
These sectors are expected to see an increase in demand, which can lead to a rise in KIMS share price in the future. Based on our analysis, we believe that KIMS Share Price Target may reach a very high position.
It’s important to keep in mind that while these price targets are based on technical analysis, there are other market conditions and news that could also impact the stock’s performance.
Hence, these target predictions should be used merely as guidelines and not as financial advice. It’s crucial to conduct your own due diligence before making any investment decisions.
Also Read – Wealth Exploration? ONGC Share Price Target 2024 2025 2030 2040
We hope you will like the information given by us. And if you want more information related to stock prediction. You can read our article and stay with us so that you can know the prediction of more stocks in the future.
Also, do your due diligence and comment to us, whether you will invest in this stock or not. Till then Happy Investing.
Disclaimer
This article KIMS Share Price Target 2024 2025 2030 2040 2050 contains information that may be useful for those interested in the stock market. However, it is important to note that Investing in the stock market can be a risky venture and is heavily influenced by market conditions. It is important to conduct thorough research and analysis before making any investment decisions.
This article has been created for educational purposes only and does not constitute investment advice. We would like to clarify that we are not registered advisors with SEBI (Stock exchange board of India) and we do not provide tips or calls regarding specific investments. [KIMS Share Price Target 2024]
It is always recommended to seek guidance from a qualified financial advisor to ensure that your investment decisions align with your financial goals and risk tolerance. Stay tuned with thepriceforecaster.com.
